| Bioactivity | KRAS G12C inhibitor 62 is a KRAS G12C inhibitor. KRAS G12C inhibitor 62 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2021121367A1)[1]. |
| Name | KRAS G12C inhibitor 62 |
| CAS | 2658588-10-2 |
| Formula | C31H26ClF4N7O2 |
| Molar Mass | 640.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Amin LI, et al. Kras mutant protein inhibitors. Patent WO2021121367A1. |
KRAS G12C inhibitor 62
CAS: 2658588-10-2 F: C31H26ClF4N7O2 W: 640.03
KRAS G12C inhibitor 62 is a KRAS G12C inhibitor. KRAS G12C inhibitor 62 has the potential for the research of KRAS G12C-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.